Promoter Sumeet Dhanraj Garad acquires 4.06% stake via share swap

Promoter bought stakeOwnership Changes View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.0%Next day

₹143.90

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-3.0%+3.0% vs market

Computers - Software & Consulting peers, median of 68sector-1.8%+1.8% vs sector

By the next day the stock moved 3.0 pts more than Nifty Microcap 250 and 1.8 pts more than its Computers - Software & Consulting peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

—-0.2—-0.5—

Next day

+0.0-3.0+3.0-1.8+1.8

—-2.7—-0.4—

—-1.9—-0.5—

+0.0-1.7+1.7+1.1-1.1

+0.0-1.0+1.0+1.2-1.2

+0.0-2.0+2.0+3.2-3.2

15d

—-6.6—-3.6—

—————

UpDownMarket · Nifty Microcap 250Sector · Computers - Software & Consulting peers, median of 68Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Promoter Sumeet Dhanraj Garad acquired 11,92,000 equity shares (4.06%) of iSERA Lifesciences through a preferential allotment on October 1, 2026. The shares came via a 1:1 share swap with Biological Limited. His total holding rose from 1,00,000 shares (1.19%) to 12,92,000 shares (5.25%). The company equity base tripled from about 8.4 crore to 24.6 crore as part of this broader capital expansion.

Likely market impact

Promoter holding rises to 5.25%, signaling confidence; share swap suggests strategic alignment with Biological Limited.